Clinical trial
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
NCT00004306 · Office of Rare Diseases (ORD), NIH · Completed
Key facts
| NCT number | NCT00004306 |
|---|---|
| Title | Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) |
| Official title | Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10) |
| Lead sponsor | Office of Rare Diseases (ORD), NIH |
| Collaborators | The University of Texas Medical Branch, Galveston |
| Status | Completed |
| Study type | Observational |
| Conditions | Hereditary Ataxia |
| Enrollment | 18 |
| Start date | Nov 1, 1999 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: